Correlation Between Twist Bioscience and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Twist Bioscience and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Twist Bioscience and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Twist Bioscience Corp and Crispr Therapeutics AG, you can compare the effects of market volatilities on Twist Bioscience and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Twist Bioscience with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Twist Bioscience and Crispr Therapeutics.
Diversification Opportunities for Twist Bioscience and Crispr Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Twist and Crispr is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Twist Bioscience Corp and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Twist Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Twist Bioscience Corp are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Twist Bioscience i.e., Twist Bioscience and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Twist Bioscience and Crispr Therapeutics
Given the investment horizon of 90 days Twist Bioscience Corp is expected to generate 1.32 times more return on investment than Crispr Therapeutics. However, Twist Bioscience is 1.32 times more volatile than Crispr Therapeutics AG. It trades about 0.1 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.03 per unit of risk. If you would invest 4,252 in Twist Bioscience Corp on August 28, 2024 and sell it today you would earn a total of 388.00 from holding Twist Bioscience Corp or generate 9.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Twist Bioscience Corp vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Twist Bioscience Corp |
| Crispr Therapeutics |
Twist Bioscience and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Twist Bioscience and Crispr Therapeutics
The main advantage of trading using opposite Twist Bioscience and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Twist Bioscience position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Twist Bioscience vs. Personalis | Twist Bioscience vs. Natera Inc | Twist Bioscience vs. Guardant Health | Twist Bioscience vs. Castle Biosciences |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |